These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4734701)

  • 1. Demonstration of complement-dependent and independent systems in immune inactivation of Mycoplasma meleagridis.
    Matsumoto M; Yamamoto R
    J Infect Dis; 1973 Mar; 127():Suppl:S43-51. PubMed ID: 4734701
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat lability of rabbit anti-Mycoplasma pneumoniae serum.
    Coleman LH; Lynn RJ
    Antonie Van Leeuwenhoek; 1972; 38(2):193-200. PubMed ID: 4537444
    [No Abstract]   [Full Text] [Related]  

  • 3. A study on the role of complement in the immune inhibition of mycoplasmal growth.
    Sethi KK; Teschner M
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):458-74. PubMed ID: 4244398
    [No Abstract]   [Full Text] [Related]  

  • 4. A division by micro-complement fixation tests of previously reported avian mycoplasma serotypes into identification groups.
    Frey ML; Hawk ST; Hale PA
    Avian Dis; 1972; 16(4):780-92. PubMed ID: 5079876
    [No Abstract]   [Full Text] [Related]  

  • 5. More sensitive methods for detection of antibody to Mycoplasma pneumoniae.
    Brunner H; Horswood RL; Chanock RM
    J Infect Dis; 1973 Mar; 127():Suppl:S52-5. PubMed ID: 4570127
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by normal rabbit sera of the growth of T-mycoplasma strains isolated from different animal species.
    Howard CJ; Gourlay RN
    J Gen Microbiol; 1973 Oct; 78(2):277-85. PubMed ID: 4762919
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune inhibition of Mycoplasma pneumoniae .
    Coleman LH; Lynn RJ
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):383-6. PubMed ID: 5037574
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of growth of Mycoplasma meleagridis by a heat-labile component of turkey, swine, and guinea pig serums.
    Saif YM; Saif LJ; Kohler EM; Bohl EH
    Am J Vet Res; 1970 Nov; 31(11):2089-94. PubMed ID: 5530955
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of complement in immune inactivation of Mycoplasma gallisepticum.
    Barker LF; Patt JK
    J Bacteriol; 1967 Aug; 94(2):403-8. PubMed ID: 4962702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-dependent and complement-independent interactions between Mycoplasma hominis and antibodies in vitro.
    Lin JS; Kass EH
    J Med Microbiol; 1975 Aug; 8(3):397-404. PubMed ID: 240941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement dependent killing of Mycoplasma pneumoniae by antibody: kinetics of the reaction.
    Gale JL; Kenny GE
    J Immunol; 1970 May; 104(5):1175-83. PubMed ID: 5444336
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth-inhibition test for identifying Mycoplasma meleagridis and its antibody.
    Ogra MS; Bohl EH
    Avian Dis; 1970 May; 14(2):364-73. PubMed ID: 5427238
    [No Abstract]   [Full Text] [Related]  

  • 13. Some effects of growth medium composition on the antigenicity of a T-strain mycoplasma.
    Masover GK; Mischak RP; Hayflick L
    Infect Immun; 1975 Mar; 11(3):530-9. PubMed ID: 803928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing of mycoplasmas by the antibodies to foreign antigens acquired by the organisms from the growth medium.
    Sethi KK; Brandis H
    Med Microbiol Immunol; 1972; 157(2):113-9. PubMed ID: 4112635
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions between Mycoplasma pneumoniae and guinea pig complement.
    Bredt W; Bitter-Suermann D
    Infect Immun; 1975 Mar; 11(3):497-504. PubMed ID: 1090534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors involved in growth-inhibition of mycoplasma by immune serum.
    Riggs S; Sharp JT; Carpenter RR
    Ann N Y Acad Sci; 1967 Jul; 143(1):784-93. PubMed ID: 4964015
    [No Abstract]   [Full Text] [Related]  

  • 17. The first component of human complement (C1): kinetics of reaction with its natural substrates.
    Strunk R; Colten HR
    J Immunol; 1974 Mar; 112(3):905-10. PubMed ID: 4811969
    [No Abstract]   [Full Text] [Related]  

  • 18. Bovine mycoplasmas: a serological study by the metabolic inhibition test.
    Erno H; Jurmanová K; Leach RH
    Acta Vet Scand; 1973; 14(4):511-23. PubMed ID: 4755761
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of immunoglobulin class and affinity on the initiation of complement-dependent damage to liposomal model membranes sensitized with dinitrophenylated phospholipids.
    Six HR; Uemura KI; Kinsky SC
    Biochemistry; 1973 Sep; 12(20):4003-11. PubMed ID: 4795683
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.